Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol (SLEAP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether the use of both a nurse-driven sedation protocol and daily sedative interruption, compared with a sedation protocol alone, result in better outcomes for mechanically ventilated adults.
| Condition | Intervention |
|---|---|
|
Critical Illness |
Procedure: Protocolized Sedation Procedure: Protocolized sedation, with daily interruption |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | A Randomized Trial of Daily Sedative Interruption in Critically Ill, Mechanically Ventilated Patients Being Managed With a Sedation Protocol |
- time to successful extubation [ Time Frame: This will be the length of time that the patient remains on continuous infusions of sedation and/or analgesia in the ICU. At 60 days, all study interventions will terminate, but patients will be followed for outcomes. ] [ Designated as safety issue: No ]
- ICU and hospital lengths of stay, ICU and hospital mortality, Adverse events (e.g., self -removal of endotracheal tube) [ Time Frame: This will be the length of time that the patient remains on continuous infusions of sedation and/or analgesia in the ICU. At 60 days, all study interventions will terminate, but patients will be followed for outcomes. ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 410 |
| Study Start Date: | January 2008 |
| Estimated Study Completion Date: | November 2011 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: PS
Nurse-directed protocols for administering sedation and/or analgesia by continuous infusion.
|
Procedure: Protocolized Sedation
Nurse-directed protocol for administering sedation and/or analgesia.
|
|
Active Comparator: PS + DI
Nurse-directed protocols for administering sedation and/or analgesia, with daily interruption of sedation/analgesia
|
Procedure: Protocolized sedation, with daily interruption
Nurse-directed protocols for administering sedation and/or analgesia, with daily interruption of sedation/analgesia
|
Detailed Description:
All critically ill, mechanically ventilated patients in the Intensive Care Unit receive medications to relieve pain and anxiety. However, accumulation of these medications can be associated with serious complications, most notably longer time on the breathing machine and in the ICU. Two strategies have been shown to dramatically improve patient outcomes: nurse-directed protocols for giving sedation, and daily interruption of sedation. However, these strategies have not been widely adopted, because of physicians' concerns, and because it is unclear which strategy is better. Given that patient outcome is improved with either of these strategies, the fundamental question that arises is whether patients managed with a combination of two strategies which both reduce drug accumulation (protocolized sedation and daily interruption) have an even better outcome than patients managed with only one of them (protocolized sedation).We are conducting a multicenter randomized trial in which 400 critically ill, mechanically ventilated patients will have their sedation managed with protocolized sedation alone, or both strategies. Primary outcomes are duration of mechanical ventilation and ICU and hospital lengths of stay. Secondary outcomes are the incidence of delirium, the use of neurologic tests, nurse and respiratory therapist effort associated with the sedation management, the incidence of patient self-removal of lines and tubes, and patient recall of the ICU stay. The results of this large multi-center trial will help to inform best practice with regard to sedation management of critically ill patients in Canada and elsewhere.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years of age or over
- Mechanically ventilated, with anticipated need for MV ≥48 hrs
- ICU team has decided to initiate continuous sedative/analgesic infusion(s)
- informed consent from patient and/or SDM
Exclusion Criteria
- Admission after resuscitation from cardiac arrest
- Traumatic brain injury
- Currently receiving neuromuscular blocking agents
- Allergy to midazolam and lorazepam
- Lack of commitment to aggressive treatment
- Previous enrolment in SLEAP, or current enrolment in related trial
Contacts and Locations| United States, California | |
| Long Beach Memorial Medical Center | |
| Long Beach, California, United States | |
| United States, Massachusetts | |
| Tuft's Medical Centre | |
| Boston, Massachusetts, United States | |
| Canada, Alberta | |
| Walter C. Mackenzie Health Sciences Centre | |
| Edmonton, Alberta, Canada, T6G 2B7 | |
| Royal Alexandra Hospital | |
| Edmonton, Alberta, Canada, T5H 3V9 | |
| Canada, British Columbia | |
| Royal Columbian Hospital | |
| New Westminster, British Columbia, Canada, V3L 3W7 | |
| Providence Health Care-St. Paul's Hospital | |
| Vancouver, British Columbia, Canada, V6Z 1Y6 | |
| Surrey Memorial Hospital | |
| Vancouver, British Columbia, Canada, V3W 1Z2 | |
| Canada, Manitoba | |
| Winnipeg Health Sciences Centre | |
| Winnipeg, Manitoba, Canada, R3A 1R9 | |
| Canada, Ontario | |
| St. Joesph's Healthcare | |
| Hamilton, Ontario, Canada, L8N 4A6 | |
| Hamilton Health Sciences | |
| Hamilton, Ontario, Canada, L8L 2X2 | |
| Toronto General Hospital | |
| Toronto, Ontario, Canada, M5G 2N2 | |
| Toronto Western Hospital | |
| Toronto, Ontario, Canada, M5T 2S8 | |
| Sunnybrook HSC | |
| Toronto, Ontario, Canada, M4N 3M5 | |
| St. Michael's Hospital | |
| Toronto, Ontario, Canada, M5B 1W8 | |
| Mount Sinai Hospital | |
| Toronto, Ontario, Canada, M5G 1X5 | |
| Canada, Quebec | |
| Maisonneuve Rosemount | |
| Montreal, Quebec, Canada, H1T 2M4 | |
| Principal Investigator: | Sangeeta Mehta, M.D. | Mount Sinai Hospital, New York |
More Information
No publications provided by Mount Sinai Hospital, Canada
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Sangeeta Mehta, M.D., Mount Sinai Hospital, Canada |
| ClinicalTrials.gov Identifier: | NCT00675363 History of Changes |
| Other Study ID Numbers: | 85487 |
| Study First Received: | May 7, 2008 |
| Last Updated: | September 23, 2011 |
| Health Authority: | Canada: Health Canada Canada: Canadian Institutes of Health Research |
Keywords provided by Mount Sinai Hospital, Canada:
|
ICU Sedation strategies Daily sedative interruption |
Sedation protocols Mechanical Ventilation Sedation |
Additional relevant MeSH terms:
|
Critical Illness Disease Attributes Pathologic Processes Hypnotics and Sedatives Central Nervous System Depressants |
Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 19, 2013